Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
Affiliations
- PMID: 32209727
- DOI: 10.18632/aging.102871
Abstract
Non-small cell lung cancer (NSCLC), which consists mainly of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), are the leading cause of cancer deaths worldwide. In this study, we performed a comprehensive analysis of the tumor microenvironmental and genetic factors to identify prognostic biomarkers for NSCLC. We evaluated the immune and stromal scores of patients with LUAD and LUSC using data from The Cancer Genome Atlas database with the ESTIMATE algorithm. Based on these scores, the differentially expressed genes were obtained and immune-related prognostic genes were identified. Functional analysis and protein-protein interaction network further revealed the immune-related biological processes in which these genes participated. Additionally, 22 subsets of tumor-infiltrating immune cells (TIICs) in the tumor microenvironment were analyzed with the CIBERSORT algorithm. Finally, we validated these valuable genes using an independent cohort from the Gene Expression Omnibus database. The associations of the immune and stromal scores with patients' clinical characteristics and prognosis were positive in LUAD but negative in LUSC and the correlations of TIICs with clinical characteristics were clarified. Several differentially expressed genes were identified to be potential immune-related prognostic genes. This study comprehensively analyzed the tumor microenvironment and presented immune-related prognostic biomarkers for NSCLC.
Keywords: GEO; TCGA; non-small cell lung cancer; prognosis; tumor microenvironment.
Similar articles
- Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.J Cell Physiol. 2020 Feb;235(2):1025-1035. doi: 10.1002/jcp.29018. Epub 2019 Jun 25.PMID: 31240705
- [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jun 30;39(6):641-649. doi: 10.12122/j.issn.1673-4254.2019.06.03.PMID: 31270041 Free PMC article. Chinese.
- The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.Biomed Pharmacother. 2017 Nov;95:55-61. doi: 10.1016/j.biopha.2017.08.003. Epub 2017 Aug 18.PMID: 28826097
- Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.Int J Oncol. 2018 Oct;53(4):1557-1579. doi: 10.3892/ijo.2018.4508. Epub 2018 Jul 30.PMID: 30066858 Free PMC article.
- High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.PLoS One. 2017 Oct 31;12(10):e0187356. doi: 10.1371/journal.pone.0187356. eCollection 2017.PMID: 29088286 Free PMC article.
No hay comentarios:
Publicar un comentario